{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:18:35Z","timestamp":1718497115302},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.reumae.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T01:57:27Z","timestamp":1718416647000},"page":"243-248","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension"],"prefix":"10.1016","volume":"20","author":[{"given":"Luis Javier","family":"Cajas Santana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Correa Giraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carolina","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2024.01.006_bib0105","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3899\/jrheum.101243","article-title":"Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population","volume":"38","author":"Hinchcliff","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0110","doi-asserted-by":"crossref","first-page":"210053","DOI":"10.1183\/16000617.0053-2021","article-title":"Pulmonary hypertension phenotypes in patients with systemic sclerosis","volume":"30","author":"Haque","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.reumae.2024.01.006_bib0115","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"[2013] Classification Criteria for Systemic Sclerosis An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"72","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.01.006_bib0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/annrheumdis-2012-202295","article-title":"Very early versus early disease: the evolving definition of the \u2018many faces\u2019 of systemic sclerosis","volume":"72","author":"Matucci-Cerinic","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.01.006_bib0125","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.01.006_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3899\/jrheum.190976","article-title":"The challenge of very early systemic sclerosis: a combination of mild and early disease?","volume":"48","author":"Blaja","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","article-title":"Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features","volume":"50","author":"Valentini","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2024.01.006_bib0140","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2024.01.006_bib0145","doi-asserted-by":"crossref","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of pulmonary hypertension","volume":"53","author":"Frost","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2024.01.006_bib0150","first-page":"447","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis","volume":"23","author":"de Azevedo","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10067-020-05296-w","article-title":"Incidence, predictors, and survival of pulmonary hypertension determined by echocardiography in Thai patients with early systemic sclerosis (SSc): inception cohort study","volume":"40","author":"Wangkaew","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0160","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reumae.2024.01.006_bib0165","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacc.2021.07.057","article-title":"Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension","volume":"78","author":"Chin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0170","first-page":"1","article-title":"[2022] ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"00","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.reumae.2024.01.006_bib0175","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"Hoeper","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.reumae.2024.01.006_bib0180","first-page":"5","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.reumae.2024.01.006_bib0185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/BOR.0000000000000440","article-title":"New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension","volume":"29","author":"Mullin","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0190","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00002281-199611000-00011","article-title":"Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension","volume":"8","author":"Wigley","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reumae.2024.01.006_bib0195","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2024.01.006_bib0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2177\/jsci.39.150","article-title":"Anti-EJ antibody positive interstitial lung disease with skin changes at the fingertips","volume":"39","author":"Ota","year":"2016","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574324000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T21:45:59Z","timestamp":1718487959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574324000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2173574324000649"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2024.01.006","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2024.01.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}